What to expect when you take Valtrex and Fioricet?

Do you take Valtrex and Fioricet? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Jun, 30, 2018

9,943 reports have been studied.


Females aged 50 to 59 :

6,692 related reports were analyzed:

Most common symptoms:

Completed suicide (act of taking one's own life)
  • 5.56% for females aged 50 (±5) who take Fioricet
Diarrhea
  • 6.47% for females aged 50 (±5) who take Valtrex
  • 5.62% for females aged 50 (±5) who take Fioricet
Dizziness
  • 6.63% for females aged 50 (±5) who take Valtrex
  • 5.07% for females aged 50 (±5) who take Fioricet
Drug ineffective
  • 7.02% for females aged 50 (±5) who take Fioricet
  • 6.47% for females aged 50 (±5) who take Valtrex
Dyspnea (difficult or laboured breathing)
  • 5.21% for females aged 50 (±5) who take Fioricet
Fatigue (feeling of tiredness)
  • 8.84% for females aged 50 (±5) who take Fioricet
  • 7.19% for females aged 50 (±5) who take Valtrex
Fever
  • 7.25% for females aged 50 (±5) who take Valtrex
Headache (pain in head)
  • 10.08% for females aged 50 (±5) who take Fioricet
  • 7.25% for females aged 50 (±5) who take Valtrex
High blood pressure
  • 6.55% for females aged 50 (±5) who take Fioricet
Joint pain
  • 8.07% for females aged 50 (±5) who take Fioricet
Nausea (feeling of having an urge to vomit)
  • 10.45% for females aged 50 (±5) who take Valtrex
  • 8.9% for females aged 50 (±5) who take Fioricet
Nausea and vomiting
  • 5.91% for females aged 50 (±5) who take Valtrex
  • 5.01% for females aged 50 (±5) who take Fioricet
Pain
  • 7.68% for females aged 50 (±5) who take Fioricet
  • 7.12% for females aged 50 (±5) who take Valtrex
Rashes (redness)
  • 6.27% for females aged 50 (±5) who take Valtrex
Stress and anxiety
  • 5.65% for females aged 50 (±5) who take Valtrex
Weakness
  • 5.19% for females aged 50 (±5) who take Valtrex
  • 5.15% for females aged 50 (±5) who take Fioricet

Most common co-existing conditions:

Depression
  • 6.06% for females aged 50 (±5) who take Fioricet
  • 5.95% for females aged 50 (±5) who take Valtrex
High blood pressure
  • 7.11% for females aged 50 (±5) who take Fioricet
  • 6.63% for females aged 50 (±5) who take Valtrex
Multiple myeloma (cancer of the plasma cells)
  • 9.7% for females aged 50 (±5) who take Valtrex
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  • 5.62% for females aged 50 (±5) who take Fioricet
  • 5.52% for females aged 50 (±5) who take Valtrex
Pain
  • 10.44% for females aged 50 (±5) who take Fioricet
  • 6.17% for females aged 50 (±5) who take Valtrex
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  • 14.79% for females aged 50 (±5) who take Fioricet
  • 5.52% for females aged 50 (±5) who take Valtrex
Stress and anxiety
  • 5.29% for females aged 50 (±5) who take Fioricet
back to top

Males aged 50 to 59 :

3,251 related reports were analyzed:

Most common symptoms:

Death
  • 7.39% for males aged 50 (±5) who take Fioricet
Dyspnea (difficult or laboured breathing)
  • 5.26% for males aged 50 (±5) who take Fioricet
Fatigue (feeling of tiredness)
  • 8.03% for males aged 50 (±5) who take Fioricet
  • 6.4% for males aged 50 (±5) who take Valtrex
Fever
  • 7.16% for males aged 50 (±5) who take Valtrex
  • 5.69% for males aged 50 (±5) who take Fioricet
Headache (pain in head)
  • 5.61% for males aged 50 (±5) who take Fioricet
High blood pressure
  • 5.69% for males aged 50 (±5) who take Fioricet
Joint pain
  • 5.4% for males aged 50 (±5) who take Fioricet
Nausea (feeling of having an urge to vomit)
  • 5.8% for males aged 50 (±5) who take Valtrex
  • 5.33% for males aged 50 (±5) who take Fioricet
Pain
  • 5.54% for males aged 50 (±5) who take Fioricet
Thrombocytopenia (decrease of platelets in blood)
  • 6.07% for males aged 50 (±5) who take Valtrex

Most common co-existing conditions:

Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
  • 5.04% for males aged 50 (±5) who take Valtrex
High blood pressure
  • 8.1% for males aged 50 (±5) who take Fioricet
  • 5.64% for males aged 50 (±5) who take Valtrex
Hiv infection
  • 7.75% for males aged 50 (±5) who take Valtrex
Multiple myeloma (cancer of the plasma cells)
  • 15.51% for males aged 50 (±5) who take Valtrex
Pain
  • 13.08% for males aged 50 (±5) who take Fioricet
  • 5.97% for males aged 50 (±5) who take Valtrex
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  • 7.04% for males aged 50 (±5) who take Fioricet
back to top

Related studies

Valtrex

Valtrex has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. (latest outcomes from Valtrex 23,986 users)

Fioricet

Fioricet has active ingredients of acetaminophen; butalbital; caffeine. It is often used in migraine. (latest outcomes from Fioricet 7,288 users)

Valtrex and Fioricet

Analysis tools (to study 526 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Valtrex, Fioricet

Recent updates

General studies
Active Support Groups
Recent Predictions

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.